Article Details
Retrieved on: 2018-03-07 18:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>JW Therapeutics, a Shangai, China-based clinical stage biopharmaceutical company, completed a $90m Series A financing. The round was led by Temasek, <b>Sequoia Capital</b> China, and YuanMing Capital, joined by other investors including Oriza Seed Capital, Yipu Capital, AVICT Global Holdings, and ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here